Adicet Bio Stock Current Valuation
| ACET Stock | USD 1.11 0.15 15.63% |
Valuation analysis of Adicet Bio helps investors to measure Adicet Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Adicet Bio's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 0.44 in 2024, despite the fact that Enterprise Value is likely to grow to (54.6 M). Fundamental drivers impacting Adicet Bio's valuation include:
Price Book 0.3741 | Enterprise Value -104.7 M | Enterprise Value Ebitda (1.21) | Price Sales 9.7185 | Enterprise Value Revenue 2.1386 |
Undervalued
Today
Please note that Adicet Bio's price fluctuation is moderately volatile at this time. Calculation of the real value of Adicet Bio is based on 3 months time horizon. Increasing Adicet Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Adicet Bio's intrinsic value may or may not be the same as its current market price of 1.11, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.11 | Real 5.89 | Target 20.33 | Hype 1.08 |
The intrinsic value of Adicet Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Adicet Bio's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Adicet Bio helps investors to forecast how Adicet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Adicet Bio more accurately as focusing exclusively on Adicet Bio's fundamentals will not take into account other important factors: Adicet Bio Company Current Valuation Analysis
Adicet Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Adicet Bio Current Valuation | (104.74 M) |
Most of Adicet Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adicet Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Adicet Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Adicet Bio is extremely important. It helps to project a fair market value of Adicet Stock properly, considering its historical fundamentals such as Current Valuation. Since Adicet Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Adicet Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Adicet Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Adicet Bio has a Current Valuation of (104.74 Million). This is 100.73% lower than that of the Health Care Providers & Services sector and 102.25% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.63% higher than that of the company.
Adicet Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adicet Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adicet Bio could also be used in its relative valuation, which is a method of valuing Adicet Bio by comparing valuation metrics of similar companies.Adicet Bio is currently under evaluation in current valuation category among its peers.
Adicet Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Adicet Bio from analyzing Adicet Bio's financial statements. These drivers represent accounts that assess Adicet Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Adicet Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 193.6M | 102.8M | 541.4M | 367.3M | 81.4M | 77.3M | |
| Enterprise Value | 297.0M | 40.2M | 284.8M | 130.6M | (57.4M) | (54.6M) |
Adicet Fundamentals
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | (104.74 M) | ||||
| Shares Outstanding | 82.4 M | ||||
| Shares Owned By Insiders | 1.59 % | ||||
| Shares Owned By Institutions | 76.43 % | ||||
| Number Of Shares Shorted | 3.65 M | ||||
| Price To Earning | 36.84 X | ||||
| Price To Book | 0.37 X | ||||
| Price To Sales | 9.72 X | ||||
| Gross Profit | 24.99 M | ||||
| EBITDA | (136.53 M) | ||||
| Net Income | (142.66 M) | ||||
| Cash And Equivalents | 260.64 M | ||||
| Cash Per Share | 6.11 X | ||||
| Total Debt | 20.92 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 16.10 X | ||||
| Book Value Per Share | 3.93 X | ||||
| Cash Flow From Operations | (93.72 M) | ||||
| Short Ratio | 7.04 X | ||||
| Earnings Per Share | (1.97) X | ||||
| Price To Earnings To Growth | 0.82 X | ||||
| Target Price | 6.4 | ||||
| Number Of Employees | 143 | ||||
| Beta | 1.7 | ||||
| Market Capitalization | 91.47 M | ||||
| Total Asset | 207.29 M | ||||
| Retained Earnings | (380.77 M) | ||||
| Working Capital | 142.99 M | ||||
| Current Asset | 352.66 M | ||||
| Current Liabilities | 98.91 M | ||||
| Five Year Return | 3.23 % | ||||
| Net Asset | 207.29 M |
About Adicet Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adicet Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adicet Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adicet Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.